We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

RFID System Helps Localize Breast Lesions

By HospiMedica International staff writers
Posted on 23 May 2017
Print article
Image: The LOCalizer RFID breast lesion localization system (Photo courtesy of Faxitron Bioptics).
Image: The LOCalizer RFID breast lesion localization system (Photo courtesy of Faxitron Bioptics).
A novel wireless radio frequency identification (RFID) system offers radiation-free breast lesion localization, resulting in better outcomes for patients.

The LOCalizer RFID breast lesion localization system includes a miniature non-radioactive RFID tag designed to be implanted in the lesion up to 30 days before surgery, a RFID tag applicator, a handheld reader, and a sterile probe. The mobile, handheld reader contains an integrated loop probe that can be used directly on the skin to determine the location and distance to the lesion and plan the surgical path with a resolution of millimeters. During resection, a single-use, pencil-sized surgical probe can be used to help guide the surgeon directly to the lesion, using audio tone guidance.

Each tag has a unique identification number and is encased in a proprietary, anti-migratory sheath, allowing for better identification of the RFID tag and keeping it in its intended position. The tag is clearly visible on ultrasound, X-ray, and magnetic resonance imaging (MRI), allowing for flexible placement with multiple imaging modalities. The LOCalizer RFID breast lesion localization system is a product of Faxitron Bioptics, and has been approved by the U.S. Food and Drug Administration (FDA).

“As the industry gets better at detecting smaller breast lesions, we must establish a new gold standard for breast lesion localization,” said Donogh O’Driscoll, CFO and COO of Faxitron. “LOCalizer could be the breakthrough needed to make lumpectomies and breast biopsies safer, more efficient, and a better experience for both providers and patients. For more than half a century, our dedication to advancing breast health has been unwavering, and we’re honored to once again pave the way for a higher standard of care.”

“The most exciting aspect of the LOCalizer technology is being able to accurately measure the distance to the target lesion, something we haven’t been able to do with other localization methods,” said Christine Dauphine, MD, of Harbor-UCLA Medical Center (Torrance, CA, USA). “Our team was able to experience the LOCalizer system first-hand in the operating room, and we were thrilled by the prospect of providing patients with a localization method that, by design, could avoid the anxiety of having additional procedures on the day of surgery.”

Traditional methods for marking non-palpable breast lesions prior to surgery require wire localization or radioactive seeds inserted by a radiologist in a separate procedure. The localization wires protrude from the patient’s breast, restricting the patient to the hospital environment. In addition, the protruding guide wires risk movement prior to surgery, requiring follow-up surgery in up to 55% of lumpectomy procedures.

Print article



view channel
Image: ‘Hologram patients’ developed to help train doctors and nurses (Photo courtesy of University of Cambridge)

Life-Like Hologram Patients Train Doctors for Real-Time Decision Making in Emergencies

A medical training project using 'mixed reality' technology aims to make consistent, high-level and relevant clinical training more accessible across the world. University of Cambridge (Cambridge, UK)... Read more

Critical Care

view channel
Image: New device could provide alternative to opioids and other highly addictive drugs (Photo courtesy of Northwestern University)

Dissolving Implantable Device Can Manage Post-Operative Pain Without Drugs

Researchers have developed a small, soft, flexible implant that relieves pain on demand without the use of drugs. The first-of-its-kind device could provide a much-needed alternative to opioids and other... Read more

Patient Care

view channel
Image: The biomolecular film can be picked up with tweezers and placed onto a wound (Photo courtesy of TUM)

Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients

Conventional bandages may be very effective for treating smaller skin abrasions, but things get more difficult when it comes to soft-tissue injuries such as on the tongue or on sensitive surfaces like... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more


view channel
Image: Expanding the role of autonomous robots can mitigate the shortage of physicians (Photo courtesy of Pexels)

Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries

An aging population and accompanying retirements will cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.